Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction.
Major histocompatibility complex (MHC) class I molecules have fundamental functions in the immune system. Recent studies have suggested that these molecules may also have non-immune functions in the nervous system, in particular related to synaptic function and plasticity. Because adult motoneurons express mRNAs for MHC class I molecules, we have examined their subcellular expression pattern in vivo and their role for the synaptic connectivity of these neurons. We observed immunoreactivity for classical MHC class I (Ia) protein in motoneuron somata, but the predominant expression was found in axons and presynaptically at neuromuscular junctions (NMJs). Peripheral nerve lesion induced a strong increase of motoneuron MHC class Ia (H2-K(b)/D(b)) mRNA, indicating a role for MHC class Ia molecules during regeneration. Accordingly, there was an accumulation of MHC class Ia proteins at the cut ends and in growth cones of motor axons after lesion. In K(b-/-)D(b-/-) mice (lacking MHC class Ia molecules), the time course for recovery of grip ability in reinnervated muscles was significantly delayed. Muscles from K(b-/-)D(b-/-) mice displayed an increased density and a disturbed distribution of NMJs and fewer terminal Schwann cells/NMJ compared with wild-type mice. A population of Schwann cells in sciatic nerves expressed the paired Ig receptor B, which binds to MHC class I molecules. These results provide the first evidence that neuronal MHC class Ia molecules are present in motor axons, that they are important for organization of NMJs and motor recovery after nerve lesion, and that their actions may be mediated via Schwann cells.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. sebastian.thams@ki.se
Sebastian
S
Thams
Petter
P
Brodin
Stefan
S
Plantman
Robert
R
Saxelin
Klas
K
Kärre
Staffan
S
Cullheim
D000818:Animals; D001369:Axons / Q000502:physiology; D002452:Cell Count; D003714:Denervation; D006183:H-2 Antigens / Q000235:genetics / Q000378:metabolism*; D064532:Histocompatibility Antigen H-2D; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009046:Motor Neurons / Q000502:physiology*; D018482:Muscle, Skeletal / Q000294:innervation / Q000473:pathology / Q000503:physiopathology; D009416:Nerve Regeneration / Q000502:physiology; D009469:Neuromuscular Junction / Q000502:physiology* / Q000503:physiopathology; D017729:Presynaptic Terminals / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000378:metabolism; D011971:Receptors, Immunologic / Q000378:metabolism; D020127:Recovery of Function / Q000502:physiology; D012583:Schwann Cells / Q000502:physiology; D012584:Sciatic Nerve / Q000293:injuries / Q000502:physiology / Q000503:physiopathology; D013116:Spinal Cord / Q000503:physiopathology; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000235:genetics / Q000378:metabolism
D006183:H-2 Antigens; C032876:H-2Kb protein, mouse; D064532:Histocompatibility Antigen H-2D; C105949:Pirb protein, mouse; D012333:RNA, Messenger; D011950:Receptors, Cholinergic; D011971:Receptors, Immunologic; D001613:beta 2-Microglobulin